SP 1017-T gene delivery systemsAlternative Names: SP 1017-T
Latest Information Update: 28 Nov 2007
At a glance
- Originator Supratek Pharma
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 09 Jan 2004 No development reported - Preclinical for Undefined in Canada (IM)
- 23 Aug 2000 Preclinical development for Undefined in Canada (IM)